Biochemical investigations into the impact of nitisinone treatment on the metabolome and assessment of whether nitisinone induced hypertyrosinaemia alters neurotransmitter metabolism [PDF]
, 2020 openaire +1 more source
SMILES-based degree molecular descriptors and machine learning for QSPR modeling of anti-alkaptonuria drugs. [PDF]
Front ChemWu G, Rasheed MW, Alsulami S.
europepmc +1 more source
Total hip arthroplasty in patients with alkaptonuria: a case report. [PDF]
Front SurgZhu B, Ruan P, Hu Z, Ding H.
europepmc +1 more source
Total Knee Arthroplasty in Alkaptonuric Patient With Ochronotic Arthropathy. [PDF]
J Am Acad Orthop Surg Glob Res RevMichalak P +3 more
europepmc +1 more source
Cardiovascular involvement in Alcaptonuria: a case report on ochronotic aortic valve. [PDF]
J Cardiothorac SurgYusifli A +5 more
europepmc +1 more source
Pediatric liver transplantation for inherited metabolic disease-Current challenges. [PDF]
Saudi J GastroenterolVara R, Hadzic N.
europepmc +1 more source
SIADH as an Underrecognized Manifestation of Porphyria-like Crises in Hereditary Tyrosinemia Type 1: Clinical and Pathophysiological Insights. [PDF]
Int J Mol SciSaraceno E +8 more
europepmc +1 more source
Human medicines European public assessment report (EPAR): Nitisinone MDK (previously Nitisinone MendeliKABS), nitisinone, Tyrosinemias, Date of authorisation: 24/08/2017, Revision: 3, Status: Authorised [PDF]
Case Medical Research, 2019 openaire +1 more source
Combined alkaptonuria and osteoporosis contributing to chronic back pain. [PDF]
Endocrinol Diabetes Metab Case RepRiegler A, Anand G.
europepmc +1 more source
Early-Onset Degenerative Bone Changes as a Manifestation of Alkaptonuria: A Case Report. [PDF]
CureusBraga R, Teixeira F, Matos C.
europepmc +1 more source